What is Immunoactiva?
Immunoactiva LLC operates within the Custom Software & IT Services industry, focusing on delivering specialized solutions. The company, which employs between 10 to 19 individuals and generates between $1M to $5M in revenue, is positioned to leverage its recent financing for further development and market expansion. The substantial capital raised indicates a late-stage growth phase, suggesting a focus on scaling operations and solidifying its market presence.
How much funding has Immunoactiva raised?
Immunoactiva has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Immunoactiva
PPP
Public-Private Partnership
What's next for Immunoactiva?
With a large-scale, late-stage funding context, Immunoactiva is poised for significant expansion. The strategic investment signals confidence from backers in the company's trajectory and its ability to execute its business plan. Future initiatives will likely involve enhancing its custom software offerings, expanding its IT service capabilities, and potentially exploring new market segments or technological advancements. This financing round is expected to fuel innovation and strengthen Immunoactiva's competitive edge in the custom software and IT services landscape.
See full Immunoactiva company page
